Consolidated cash flow statements
(unaudited)
|
Three months ended 31 March |
|
(thousands of €) |
2020 |
2019 |
Net loss of the period |
(50,601) |
(48,656) |
|
|
|
Adjustment for non-cash transactions |
22,935 |
5,524 |
Adjustment for items to disclose separately under operating cash flow |
(747) |
(1,517) |
Adjustment for items to disclose under investing and financing cash flows |
(2,596) |
(3) |
Change in working capital other than deferred income |
52,481 |
(2,294) |
Decrease in deferred income |
(91,677) |
(25,979) |
|
|
|
Cash used in operations |
(70,205) |
(72,925) |
|
|
|
Interest paid |
(171) |
(327) |
Interest received |
2,745 |
1,565 |
Corporate taxes paid |
(1,243) |
(11) |
|
|
|
Net cash flows used in operating activities |
(68,874) |
(71,698) |
|
|
|
Purchase of property, plant and equipment |
(2,866) |
(2,103) |
Purchase of and expenditure in intangible fixed assets |
(10,159) |
(1,201) |
Proceeds from disposal of property, plant and equipment |
- |
1 |
Purchase of current financial investments |
(2,187,948) |
- |
Interest received related to current financial investments |
2,596 |
- |
Sale of current financial investments |
3,130,686 |
- |
Acquisition of financial assets |
(2,670) |
(177) |
Proceeds from sale of financial assets held at fair value through profit or loss |
- |
82 |
|
|
|
Net cash flows generated/used (-) in investing activities |
929,640 |
(3,398) |
|
|
|
Payment of lease liabilities |
(1,425) |
(1,248) |
Proceeds from capital and share premium increases from exercise of warrants |
5,355 |
3,481 |
|
|
|
Net cash flows generated in financing activities |
3,930 |
2,233 |
|
|
|
Increase/ |
864,695 |
(72,863) |
|
|
|
Cash and cash equivalents at beginning of year |
1,861,616 |
1,290,796 |
|
|
|
Increase/ |
864,695 |
(72,863) |
|
|
|
Effect of exchange rate differences on cash and cash equivalents |
17,261 |
4,968 |
|
|
|
Cash and cash equivalents at end of the period |
2,743,573 |
1,222,901 |
The accompanying notes form an integral part of these condensed consolidated financial statements.
|
31 March |
|
(thousands of €) |
2020 |
2019 |
Current financial investments |
2,978,805 |
- |
Cash and cash equivalents |
2,743,573 |
1,222,901 |
Current financial investments and cash and cash equivalents |
5,722,378 |
1,222,901 |
The accompanying notes form an integral part of these condensed consolidated financial statements.